Key points are not available for this paper at this time.
Our results suggest that maintaining an RDI ≥75% during the initial 8 weeks of lenvatinib treatment has a favorable impact on response.
Share your take
Add a clinician perspective alongside expert commentary.
Takahashi et al. (2019) studied this question.